Skip to content

Molecular mechanisms of sequelae in patients recovering from COVID-19

Molecular mechanisms of sequelae in patients recovering from COVID-19

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054043
Enrollment
Unknown
Registered
2021-12-07
Start date
2021-12-20
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Physical dysfunction group vs inorganic dysfunction group:Nil

Sponsors

Beijing Chaoyang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Confirmed and cured adult (>=18 years old) cases that meet the diagnostic criteria for new coronary pneumonia in the "Notice on Printing and Distributing the New Coronary Virus Pneumonia Diagnosis and Treatment Plan (Trial Eighth Edition)"; 2. I or my entrusted agent understand the entire research purpose, voluntarily participate in the research and sign the informed consent form, agree to cooperate with relevant assessment and inspection, and agree to collect clinical samples.

Exclusion criteria

Exclusion criteria: Pregnant or breastfeeding women and those with mental disorders that affect communication.

Design outcomes

Primary

MeasureTime frame
Clinical assessments of COVID-19 sequelae (Type of COVID-19 sequelae);Association between genetic factors and COVID-19 sequelae;Association between immunological patterns and COVID-19 sequelae;Association between trans-omics landscape and COVID-19 sequelae;Laboratory test;High-resolution CT of the chest;Pulmonary function test;

Countries

China

Contacts

Public ContactTong Zhaohui

Beijing Chaoyang Hospital, Capital Medical University

tongzhaohuicy@sina.com+86 13910930309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026